1. Home
  2. DSX vs GLSI Comparison

DSX vs GLSI Comparison

Compare DSX & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diana Shipping inc. common stock

DSX

Diana Shipping inc. common stock

HOLD

Current Price

$2.22

Market Cap

291.1M

ML Signal

HOLD

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

HOLD

Current Price

$14.77

Market Cap

272.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSX
GLSI
Founded
1999
2006
Country
Greece
United States
Employees
939
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
291.1M
272.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
DSX
GLSI
Price
$2.22
$14.77
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$50.00
AVG Volume (30 Days)
616.8K
138.7K
Earning Date
05-28-2026
05-19-2026
Dividend Yield
1.62%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.28
N/A
Revenue Next Year
$4.87
N/A
P/E Ratio
$16.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$7.78
52 Week High
$2.92
$34.10

Technical Indicators

Market Signals
Indicator
DSX
GLSI
Relative Strength Index (RSI) 53.22 32.31
Support Level $2.17 $8.19
Resistance Level $2.24 $29.89
Average True Range (ATR) 0.07 2.10
MACD 0.02 -0.48
Stochastic Oscillator 90.00 15.84

Price Performance

Historical Comparison
DSX
GLSI

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize, and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods, including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers, through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation; the services provided by the vessels are similar, and all operate under the same economic environment.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.

Share on Social Networks: